{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:44:26Z","timestamp":1793922266523,"version":"4.8.0"},"reference-count":456,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple sclerosis affects a significant portion of the world\u2019s adult population and is the most common nontraumatic neuroimmunology disorder. Although the specific etiology of multiple sclerosis remains unknown, it has been associated with autoimmune components. While current treatment options relieve some symptoms in MS patients, most are immunosuppressive and only delay the progression of the disease without conferring definitive curative measures. Hence, a thorough understanding of disease pathobiology, the contribution of the neurovascular unit (NVU), and biological body-on-a-chip systems that replicate the blood\u2013brain barrier may open new horizons for the discovery of potential therapeutics for MS.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1595276","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:30Z","timestamp":1749528630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with in vitro blood\u2013brain barrier models"],"prefix":"10.3389","volume":"16","author":[{"given":"Aya A.","family":"El-Taibany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehr","family":"Heydarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Porada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Seeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Atala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s100720070027","article-title":"Early onset multiple sclerosis","volume":"21","author":"Simone","year":"2000","journal-title":"Neurol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.952161","article-title":"Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019","volume":"10","author":"Ding","year":"2022","journal-title":"Front Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2002\/745764","article-title":"Multiple sclerosis and Epstein-Barr virus","volume":"13","author":"Marrie","year":"2002","journal-title":"Can J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"Lunemann","year":"2008","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr197","article-title":"Epstein-Barr virus in the multiple sclerosis brain: a controversial issue\u2013report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"Lassmann","year":"2011","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2019.0015","article-title":"Vitamin D as an immune modulator in multiple sclerosis","volume":"53","author":"Bartosik-Psujek","year":"2019","journal-title":"Neurol Neurochir Pol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0590-9","article-title":"Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity","volume":"88","author":"Kamen","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1568010042634596","article-title":"Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs","volume":"3","author":"May","year":"2004","journal-title":"Curr Drug Targets Inflammation Allergy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02122.x","article-title":"Smoke exposure increases the risk for multiple sclerosis","volume":"15","author":"Sundstrom","year":"2008","journal-title":"Eur J Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta-analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usz421","article-title":"Multiple sclerosis exacerbation associated with high-altitude climbing exposure","volume":"185","author":"Hsieh","year":"2020","journal-title":"Mil Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab104","article-title":"The latitude gradient for multiple sclerosis prevalence is established in the early life course","volume":"144","author":"Sabel","year":"2021","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrneurol.2016.181","article-title":"Multiple sclerosis: Latitude and vitamin D influence disease course in multiple sclerosis","volume":"13","author":"Wood","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1932604100","article-title":"Twin concordance and sibling recurrence rates in multiple sclerosis","volume":"100","author":"Willer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1018","article-title":"Genome-wide association studies of multiple sclerosis","volume":"7","author":"Cotsapas","year":"2018","journal-title":"Clin Transl Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0236-y","article-title":"Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis","volume":"24","author":"Falcao","year":"2018","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: A comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J Autoimmun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s42003-023-04713-5","article-title":"Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes","volume":"6","author":"Ma","year":"2023","journal-title":"Commun Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac420","article-title":"Novel plasma and brain proteins that are implicated in multiple sclerosis","volume":"146","author":"Lin","year":"2023","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00281-021-00907-3","article-title":"Genetics and functional genomics of multiple sclerosis","volume":"44","author":"Kim","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.24607","article-title":"Cause and prevention of demyelination in a model multiple sclerosis lesion","volume":"79","author":"Desai","year":"2016","journal-title":"Ann Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.012","article-title":"Revised diagnostic criteria of multiple sclerosis","volume":"13","author":"Milo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Katz Sand","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"B38","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P T"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.2018.28.issue-5","article-title":"Magnetic resonance imaging correlates of neuro-axonal pathology in the MS spinal cord","volume":"28","author":"Schmierer","year":"2018","journal-title":"Brain Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2007.00805.x","article-title":"Remyelination can be extensive in multiple sclerosis despite a long disease course","volume":"33","author":"Patani","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.6.1085","article-title":"Primary progressive multiple sclerosis","volume":"120","author":"Thompson","year":"1997","journal-title":"Brain"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq250","article-title":"Demyelination versus remyelination in progressive multiple sclerosis","volume":"133","author":"Bramow","year":"2010","journal-title":"Brain"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.4.759","article-title":"A comparison of the pathology of primary and secondary progressive multiple sclerosis","volume":"117","author":"Revesz","year":"1994","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240408","article-title":"Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens","volume":"24","author":"Hayashi","year":"1988","journal-title":"Ann Neurol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(83)90201-0","article-title":"Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis","volume":"62","author":"Booss","year":"1983","journal-title":"J Neurol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"MaChado-Santos","year":"2018","journal-title":"Brain"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nat Genet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.192.3.393","article-title":"Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction","volume":"192","author":"Babbe","year":"2000","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/brain\/awf059","article-title":"Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients","volume":"125","author":"Jacobsen","year":"2002","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010201107","article-title":"Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence","volume":"107","author":"Wakim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.08.017","article-title":"Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination","volume":"29","author":"Thieu","year":"2008","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ni.1969","article-title":"T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"B67","article-title":"The role of B cells in multiple sclerosis: more than antibodies","volume":"22","author":"Funaro","year":"2016","journal-title":"Discov Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1568407","article-title":"B cell depletion in the treatment of multiple sclerosis","volume":"19","author":"Myhr","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160716576","article-title":"B cells and autoantibodies in multiple sclerosis","volume":"16","author":"Probstel","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1052-y","article-title":"Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex","volume":"125","author":"Witte","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0022-510X(90)90004-7","article-title":"Immunological and neuropathological significance of the Virchow-Robin space","volume":"100","author":"Esiri","year":"1990","journal-title":"J Neurol Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30245-X","article-title":"Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study","volume":"17","author":"Trapp","year":"2018","journal-title":"Lancet Neurol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307712","article-title":"Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron","volume":"85","author":"Haider","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/NEN.0b013e3181a19a5a","article-title":"Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter","volume":"68","author":"Vercellino","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.198192","article-title":"Hypothalamic lesions in multiple sclerosis","volume":"82","author":"Qiu","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001008","article-title":"Neuroinflammation in the normal-appearing white matter (NAWM) of the multiple sclerosis brain causes abnormalities at the nodes of Ranvier","volume":"18","author":"Gallego-Delgado","year":"2020","journal-title":"PLoS Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22230","article-title":"A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23313","article-title":"Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis","volume":"66","author":"Chiou","year":"2018","journal-title":"Glia"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.2.255","article-title":"Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study","volume":"45","author":"Filippi","year":"1995","journal-title":"Neurology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.12.2540","article-title":"In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis","volume":"124","author":"Rovaris","year":"2001","journal-title":"Brain"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0243-9","article-title":"Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis","volume":"250","author":"Miller","year":"2003","journal-title":"J Neurol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0992-5","article-title":"A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging\u2013evidence of Wallerian degeneration","volume":"250","author":"Ciccarelli","year":"2003","journal-title":"J Neurol"},{"key":"B94","article-title":"Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis","volume":"24","author":"Ge","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B","article-title":"Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients","volume":"48","author":"Bjartmar","year":"2000","journal-title":"Ann Neurol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/135245859800400203","article-title":"Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions","volume":"4","author":"Mews","year":"1998","journal-title":"Mult Scler"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s100720170012","article-title":"Pathological abnormalities in the normal-appearing white matter in multiple sclerosis","volume":"22","author":"Allen","year":"2001","journal-title":"Neurol Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.9.1845","article-title":"Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis","volume":"123","author":"Evangelou","year":"2000","journal-title":"Brain"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22054","article-title":"Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords","volume":"68","author":"Androdias","year":"2010","journal-title":"Ann Neurol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0002-z","article-title":"Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss","volume":"255","author":"Moore","year":"2008","journal-title":"J Neurol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510384008","article-title":"Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology","volume":"17","author":"Laule","year":"2011","journal-title":"Mult Scler"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2013.12.001","article-title":"Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI","volume":"4","author":"Cramer","year":"2014","journal-title":"NeuroImage Clin"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21800","article-title":"Multiple sclerosis: distribution of inflammatory cells in newly forming lesions","volume":"66","author":"Henderson","year":"2009","journal-title":"Ann Neurol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32832b4c76","article-title":"Preactive lesions in multiple sclerosis","volume":"22","author":"van der Valk","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.08.007","article-title":"Regulation of tight junctions and loss of barrier function in pathophysiology","volume":"36","author":"Harhaj","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(03)00177-2","article-title":"Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist\u2019s view","volume":"42","author":"Vorbrodt","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.104.3.773","article-title":"Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat","volume":"104","author":"Schulze","year":"1993","journal-title":"J Cell Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(01)00102-3","article-title":"Molecular and cellular permeability control at the blood-brain barrier","volume":"36","author":"Gloor","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"B111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1113\/jphysiol.1990.sp018243","article-title":"Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study","volume":"429","author":"Butt","year":"1990","journal-title":"J Physiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.6.1777","article-title":"Occludin: a novel integral membrane protein localizing at tight junctions","volume":"123","author":"Furuse","year":"1993","journal-title":"J Cell Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.141.7.1539","article-title":"Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin","volume":"141","author":"Furuse","year":"1998","journal-title":"J Cell Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.11.12.4131","article-title":"Complex phenotype of mice lacking occludin, a component of tight junction strands","volume":"11","author":"Saitou","year":"2000","journal-title":"Mol Biol Cell"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81553-6","article-title":"CNS myelin and sertoli cell tight junction strands are absent in Osp\/claudin-11 null mice","volume":"99","author":"Gow","year":"1999","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(00)02004-X","article-title":"Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier","volume":"24","author":"Huber","year":"2001","journal-title":"Trends Neurosci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20164016","article-title":"Potential for tight junction protein-directed drug development using claudin binders and angubindin-1","volume":"20","author":"Hashimoto","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.156","article-title":"Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia","volume":"23","author":"Greene","year":"2018","journal-title":"Mol Psychiatry"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.45.29745","article-title":"The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton","volume":"273","author":"Fanning","year":"1998","journal-title":"J Biol Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.93.1.107","article-title":"Cingulin: characterization and localization","volume":"93","author":"Citi","year":"1989","journal-title":"J Cell Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.120.2.477","article-title":"Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2","volume":"120","author":"Zhong","year":"1993","journal-title":"J Cell Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3699","article-title":"Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members","volume":"98","author":"Aurrand-Lions","year":"2001","journal-title":"Blood"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M905251199","article-title":"Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin","volume":"275","author":"Bazzoni","year":"2000","journal-title":"J Biol Chem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.109.2.437","article-title":"Identification of alpha v beta 3 as a heterotypic ligand for CD31\/PECAM-1","volume":"109","author":"Buckley","year":"1996","journal-title":"J Cell Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0213595","article-title":"Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice","volume":"109","author":"Graesser","year":"2002","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199411000-00010","article-title":"Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study","volume":"53","author":"Kwon","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/nen.0b013e318040b2de","article-title":"The blood-brain barrier in cortical multiple sclerosis lesions","volume":"66","author":"van Horssen","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.04.066","article-title":"How do immune cells overcome the blood-brain barrier in multiple sclerosis","volume":"585","author":"Larochelle","year":"2011","journal-title":"FEBS Lett"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3275","article-title":"Will the real multiple sclerosis please stand up","volume":"13","author":"Stys","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis","volume":"113","author":"Kermode","year":"1990","journal-title":"Pathogenetic Clin implications. Brain"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1689","article-title":"A serial study of new MS lesions and the white matter from which they arise","volume":"51","author":"Goodkin","year":"1998","journal-title":"Neurology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells","volume":"2","author":"Kaech","year":"2001","journal-title":"Nat Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2920-0_38","article-title":"Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis","volume":"331","author":"Dore-Duffy","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19388","article-title":"Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease","volume":"113","author":"Waldner","year":"2004","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/87730","article-title":"Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation","volume":"2","author":"van Stipdonk","year":"2001","journal-title":"Nat Immunol"},{"key":"B138","first-page":"189","article-title":"Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL\/J mouse","volume":"145","author":"Steffen","year":"1994","journal-title":"Am J Pathol"},{"key":"B139","article-title":"Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off","volume":"86","author":"Greenwood","year":"1995","journal-title":"Immunology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws212","article-title":"Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system","volume":"135","author":"Larochelle","year":"2012","journal-title":"Brain"},{"key":"B141","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ana.24415","article-title":"Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation","volume":"78","author":"Larochelle","year":"2015","journal-title":"Ann Neurol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.065","article-title":"Inflammatory th17 cells express integrin alphavbeta3 for pathogenic function","volume":"16","author":"Du","year":"2016","journal-title":"Cell Rep"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330614","article-title":"Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy","volume":"33","author":"Tsukada","year":"1993","journal-title":"Ann Neurol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380210","article-title":"Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging","volume":"38","author":"Hartung","year":"1995","journal-title":"Ann Neurol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1557","article-title":"Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging","volume":"48","author":"Giovannoni","year":"1997","journal-title":"Neurology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400700","article-title":"Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier","volume":"193","author":"Winger","year":"2014","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.2016.273.issue-1","article-title":"Transendothelial migration: unifying principles from the endothelial perspective","volume":"273","author":"Muller","year":"2016","journal-title":"Immunol Rev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445125","article-title":"Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier","volume":"45","author":"Abadier","year":"2015","journal-title":"Eur J Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2017.56","article-title":"IFN-gamma promotes transendothelial migration of CD4(+) T cells across the blood-brain barrier","volume":"95","author":"Sonar","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2013the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.2000.2288","article-title":"Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function","volume":"61","author":"Oshima","year":"2001","journal-title":"Microvasc Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.113.11.2085","article-title":"Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma","volume":"113","author":"Mankertz","year":"2000","journal-title":"J Cell Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00399.x","article-title":"Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB activation","volume":"78","author":"Wachtel","year":"2001","journal-title":"J Neurochem"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200207000-00015","article-title":"The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability","volume":"18","author":"Nwariaku","year":"2002","journal-title":"Shock"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2000.279.5.G851","article-title":"Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells","volume":"279","author":"Nusrat","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/0531-5565(79)90026-3","article-title":"Genetics of longevity in Drosophila\u2013I. The effects of w, m and f mutant genes in various genotype combinations","volume":"14","author":"Unlu","year":"1979","journal-title":"Exp Gerontol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.1.H286","article-title":"Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines","volume":"273","author":"Blum","year":"1997","journal-title":"Am J Physiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.6164","article-title":"Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms","volume":"171","author":"Bruewer","year":"2003","journal-title":"J Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00058-X","article-title":"Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo","volume":"86","author":"Bolton","year":"1998","journal-title":"Neuroscience"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.549592","article-title":"Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice","volume":"40","author":"Sozen","year":"2009","journal-title":"Stroke"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J Neurosci"},{"key":"B165","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.33.23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti","year":"1999","journal-title":"J Biol Chem"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092872","article-title":"Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS One"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms916oa","article-title":"Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J Exp Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-013-0357-9","article-title":"Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study","volume":"119","author":"Conforti","year":"2014","journal-title":"Radiol Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2006.08.005","article-title":"Extensive extracellular matrix depositions in active multiple sclerosis lesions","volume":"24","author":"van Horssen","year":"2006","journal-title":"Neurobiol Dis"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04897.x","article-title":"The extracellular matrix in multiple sclerosis pathology","volume":"103","author":"van Horssen","year":"2007","journal-title":"J Neurochem"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514540358","article-title":"Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration","volume":"21","author":"Kilsdonk","year":"2015","journal-title":"Mult Scler"},{"key":"B174","article-title":"The action of organic cadmium complexes of different degrees of hydrophobicity on rat liver mitochondria","volume":"38","author":"Korotkov","year":"1996","journal-title":"Tsitologiia"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.2960","article-title":"Blood-brain barrier permeability and gadolinium: benefits and potential pitfalls in research","volume":"73","author":"Montagne","year":"2016","journal-title":"JAMA Neurol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood-brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2013chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3109\/08941939109140777","article-title":"Prolonged simple cryothermic immersion storage of rat heart isografts: a preliminary study","volume":"4","author":"Ding","year":"1991","journal-title":"J Invest Surg"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00749.x","article-title":"Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies","volume":"115","author":"Szczucinski","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.462","article-title":"Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL\/6 mice","volume":"171","author":"Oliver","year":"2003","journal-title":"J Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110434","article-title":"Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE","volume":"208","author":"Rothhammer","year":"2011","journal-title":"J Exp Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat Immunol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.1.20","article-title":"Matrix metalloproteinases in inflammatory demyelination: targets for treatment","volume":"53","author":"Kieseier","year":"1999","journal-title":"Neurology"},{"key":"B184","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.7.1283","article-title":"Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies","volume":"122","author":"Westland","year":"1999","journal-title":"Brain"},{"key":"B188","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1750-3639.1991.tb00646.x","article-title":"Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation","volume":"1","author":"Hickey","year":"1991","journal-title":"Brain Pathol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin Neurol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00260-9","article-title":"T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects","volume":"84","author":"Trotter","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1177\/135245859600100503","article-title":"T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls","volume":"1","author":"Pelfrey","year":"1996","journal-title":"Mult Scler"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3893","article-title":"Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis","volume":"172","author":"Bielekova","year":"2004","journal-title":"J Immunol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"287ra74","DOI":"10.1126\/scitranslmed.aaa8038","article-title":"Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis","volume":"7","author":"Cao","year":"2015","journal-title":"Sci Transl Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"B195","doi-asserted-by":"publisher","first-page":"170ra15","DOI":"10.1126\/scitranslmed.3004970","article-title":"In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling","volume":"5","author":"Schneider","year":"2013","journal-title":"Sci Transl Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt108","article-title":"HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis","volume":"136","author":"Mohme","year":"2013","journal-title":"Brain"},{"key":"B197","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","article-title":"Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis","volume":"175","author":"Jelcic","year":"2018","journal-title":"Cell"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838371","article-title":"Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy","volume":"38","author":"Stinissen","year":"2008","journal-title":"Eur J Immunol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1957","article-title":"Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain","volume":"15","author":"Wu","year":"2009","journal-title":"Nat Med"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.11.030","article-title":"Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor","volume":"155","author":"Parkhurst","year":"2013","journal-title":"Cell"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.01.037","article-title":"Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration","volume":"10","author":"Song","year":"2015","journal-title":"Cell Rep"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1079-9","article-title":"Is MS an inflammatory or primary degenerative disease","volume":"120","author":"Losy","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1380","article-title":"Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury","volume":"53","author":"Bever","year":"1999","journal-title":"Neurology"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514522104","article-title":"To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis","volume":"20","author":"Schirmer","year":"2014","journal-title":"Mult Scler"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/nature10851","article-title":"Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity","volume":"483","author":"Jiang","year":"2012","journal-title":"Nature"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann Neurol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jnen\/62.6.593","article-title":"The blood-brain barrier and its role in immune privilege in the central nervous system","volume":"62","author":"Pachter","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0154","article-title":"How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes","volume":"107","author":"Hatterer","year":"2006","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0774-y","article-title":"CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system","volume":"121","author":"Prodinger","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71544","article-title":"Immune cell trafficking from the brain maintains CNS immune tolerance","volume":"124","author":"Mohammad","year":"2014","journal-title":"J Clin Invest"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052586","article-title":"The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation","volume":"8","author":"Wheway","year":"2013","journal-title":"PLoS One"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13149","article-title":"Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration","volume":"5","author":"Lopes Pinheiro","year":"2016","journal-title":"Elife"},{"key":"B216","first-page":"37","article-title":"Kinetics of MHC gene expression and mRNA synthesis in brain endothelium","volume":"63","author":"Male","year":"1988","journal-title":"Immunology"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3062","article-title":"Primary oligodendrocyte death does not elicit anti-CNS immunity","volume":"15","author":"Locatelli","year":"2012","journal-title":"Nat Neurosci"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.06.011","article-title":"Immune response in leukodystrophies","volume":"37","author":"Eichler","year":"2007","journal-title":"Pediatr Neurol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-007-0079-y","article-title":"Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM","volume":"39","author":"Templeton","year":"2007","journal-title":"Immunol Res"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"key":"B221","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/brain\/121.1.3","article-title":"The role of magnetic resonance techniques in understanding and managing multiple sclerosis","volume":"121","author":"Miller","year":"1998","journal-title":"Brain"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(92)90500-2","article-title":"Turnover of resident microglia in the normal adult mouse brain","volume":"48","author":"Lawson","year":"1992","journal-title":"Neuroscience"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/nature13989","article-title":"Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors","volume":"518","author":"Gomez Perdiguero","year":"2015","journal-title":"Nature"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.03.011","article-title":"C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages","volume":"42","author":"Hoeffel","year":"2015","journal-title":"Immunity"},{"key":"B225","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.celrep.2016.12.041","article-title":"Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain","volume":"18","author":"Askew","year":"2017","journal-title":"Cell Rep"},{"key":"B226","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0003-9969(75)90144-2","article-title":"Effects of mandibular displacement on the metabolic activity of the masseter muscle in rat","volume":"20","author":"Enger","year":"1975","journal-title":"Arch Biol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701783","article-title":"Pleiotropic impacts of macrophage and microglial deficiency on development in rats with targeted mutation of the csf1r locus","volume":"201","author":"Pridans","year":"2018","journal-title":"J Immunol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuron.2017.12.002","article-title":"Microglial ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1","volume":"97","author":"Madry","year":"2018","journal-title":"Neuron"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00050","article-title":"Cyclic AMP pathway suppress autoimmune neuroinflammation by inhibiting functions of encephalitogenic CD4 T cells and enhancing M2 macrophage polarization at the site of inflammation","volume":"9","author":"Veremeyko","year":"2018","journal-title":"Front Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"key":"B235","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","article-title":"Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons","volume":"125","author":"Singh","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann Neurol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201847540","article-title":"Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelination","volume":"48","author":"Wolf","year":"2018","journal-title":"Eur J Immunol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.08.040","article-title":"Free radicals, mitochondria, and hypoxia-ischemia in the developing brain","volume":"40","author":"Blomgren","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101815","article-title":"Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions","volume":"9","author":"Rochfort","year":"2014","journal-title":"PLoS One"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2030fje","article-title":"An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization","volume":"19","author":"Weaver","year":"2005","journal-title":"FASEB J"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2006.00766.x","article-title":"Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions","volume":"32","author":"van Horssen","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1159\/000369933","article-title":"Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases","volume":"15","author":"Fakhoury","year":"2015","journal-title":"Neurodegener Dis"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","article-title":"Danger-associated molecular patterns in Alzheimer\u2019s disease","volume":"101","author":"Venegas","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat Med"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf235","article-title":"Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time","volume":"125","author":"Kuhlmann","year":"2002","journal-title":"Brain"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn354","article-title":"Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization","volume":"132","author":"Siffrin","year":"2009","journal-title":"Brain"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1433000100","article-title":"Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin","volume":"100","author":"Kivisakk","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0245-0","article-title":"Role of microglia in neurological disorders and their potentials as a therapeutic target","volume":"54","author":"Du","year":"2017","journal-title":"Mol Neurobiol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn109","article-title":"Debris clearance by microglia: an essential link between degeneration and regeneration","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141656","article-title":"Inefficient clearance of myelin debris by microglia impairs remyelinating processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J Exp Med"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0801218","article-title":"CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis","volume":"182","author":"Wolf","year":"2009","journal-title":"J Immunol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6337-x","article-title":"Decreased microglial activation in MS patients treated with glatiramer acetate","volume":"259","author":"Ratchford","year":"2012","journal-title":"J Neurol"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1719902115","article-title":"Bryostatin-1 alleviates experimental multiple sclerosis","volume":"115","author":"Kornberg","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B257","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.biopha.2017.09.110","article-title":"Anti-encephalitogenic effects of ethyl pyruvate are reflected in the central nervous system and the gut","volume":"96","author":"Djedovic","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B258","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2004.08.011","article-title":"Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination","volume":"158","author":"Li","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat Neurosci"},{"key":"B261","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-2094-11-7","article-title":"Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons","volume":"11","author":"Huang","year":"2014","journal-title":"J Neuroinflammation"},{"key":"B262","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1742-2094-10-89","article-title":"Reduction of microglial activity in a model of multiple sclerosis by dipyridamole","volume":"10","author":"Sloka","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.03.003","article-title":"Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia\/macrophages and increased angiogenesis and neurogenesis following experimental stroke","volume":"40","author":"Jin","year":"2014","journal-title":"Brain Behav Immun"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.4.655","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1433000100","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"B267","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"key":"B269","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001170","article-title":"Treatment of multiple sclerosis","volume":"28","author":"Cross","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"B271","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.0405","article-title":"Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study: A randomized clinical trial","volume":"78","author":"Kappos","year":"2021","journal-title":"JAMA Neurol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70308-9","article-title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Confavreux","year":"2014","journal-title":"Lancet Neurol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014656","article-title":"Randomized trial of oral teriflunomide for relapsing multiple sclerosis","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70191-7","article-title":"Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Miller","year":"2014","journal-title":"Lancet Neurol"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1025755","article-title":"Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety","volume":"15","author":"Dubey","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s6627","article-title":"Identification of targets and new developments in the treatment of multiple sclerosis\u2013focus on cladribine","volume":"4","author":"Warnke","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H037","article-title":"Cladribine: an investigational immunomodulatory agent for multiple sclerosis","volume":"40","author":"Brousil","year":"2006","journal-title":"Ann Pharmacother"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"key":"B281","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1352458514549398","article-title":"Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis","volume":"21","author":"Hartung","year":"2015","journal-title":"Mult Scler"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0412-5","article-title":"Outcome measures in clinical trials for multiple sclerosis","volume":"31","author":"van Munster","year":"2017","journal-title":"CNS Drugs"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318233b240","article-title":"A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS","volume":"77","author":"Freedman","year":"2011","journal-title":"Neurology"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17101-8","article-title":"Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial","volume":"364","author":"Hommes","year":"2004","journal-title":"Lancet"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70159-5","article-title":"Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial","volume":"12","author":"Zajicek","year":"2013","journal-title":"Lancet Neurol"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.5.1145","article-title":"Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group","volume":"54","author":"Rice","year":"2000","journal-title":"Neurology"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303291","article-title":"Interferon beta for secondary progressive multiple sclerosis: a systematic review","volume":"84","author":"La Mantia","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70243-0","article-title":"Primary-progressive multiple sclerosis","volume":"6","author":"Miller","year":"2007","journal-title":"Lancet Neurol"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)12023-X","article-title":"Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial","volume":"360","author":"Hartung","year":"2002","journal-title":"Lancet"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.11.1496","article-title":"Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"Kapoor","year":"2018","journal-title":"Lancet Neurol"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx037","article-title":"Efficiency of antibody therapy in demyelinating diseases","volume":"29","author":"Akaishi","year":"2017","journal-title":"Int Immunol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917246","article-title":"Ofatumumab versus teriflunomide in multiple sclerosis","volume":"383","author":"Hauser","year":"2020","journal-title":"N Engl J Med"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201904","article-title":"Ublituximab versus teriflunomide in relapsing multiple sclerosis","volume":"387","author":"Steinman","year":"2022","journal-title":"N Engl J Med"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517713147","article-title":"Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod","volume":"23","author":"Ghadiri","year":"2017","journal-title":"Mult Scler"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"B301","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","article-title":"Animal models of multiple sclerosis\u2013potentials and limitations","volume":"92","author":"Mix","year":"2010","journal-title":"Prog Neurobiol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jnr.24528","article-title":"Biological models in multiple sclerosis","volume":"98","author":"Sanabria-Castro","year":"2020","journal-title":"J Neurosci Res"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J Neurosci Res"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.05.002","article-title":"Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely","volume":"3","author":"Baker","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.285","article-title":"Active induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat Protoc"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.284","article-title":"Passive induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat Protoc"},{"key":"B307","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2011.09.002","article-title":"Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond","volume":"1","author":"Kipp","year":"2012","journal-title":"Mult Scler Relat Disord"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(70)90121-8","article-title":"Increased protease activity and changes in basic proteins and lipids in multiple sclerosis plaques","volume":"11","author":"Einstein","year":"1970","journal-title":"J Neurol Sci"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1084\/jem.115.4.777","article-title":"The encephalomyelitic activity of myelin isolated by ultracentrifugation","volume":"115","author":"Laatsch","year":"1962","journal-title":"J Exp Med"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.141.4.1126","article-title":"A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis","volume":"141","author":"Tuohy","year":"1988","journal-title":"J Immunol"},{"key":"B311","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0165-5728(81)90004-7","article-title":"Detection of antibodies to myelin basic protein by solid-phase radioimmunoassay with [125I]protein A","volume":"1","author":"Linthicum","year":"1981","journal-title":"J Neuroimmunol"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160406121218","article-title":"Preclinical models of multiple sclerosis: advantages and limitations towards better therapies","volume":"23","author":"Didonna","year":"2016","journal-title":"Curr Med Chem"},{"key":"B313","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-45558-2","article-title":"Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis","volume":"25","author":"Lassmann","year":"1983","journal-title":"Schriftenr Neurol"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B315","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/WCO.0b013e3282f419ca","article-title":"Optic neuritis and multiple sclerosis","volume":"21","author":"Plant","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"B316","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1742-2094-9-187","article-title":"Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain","volume":"9","author":"Schmitt","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.01.001","article-title":"Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"30","author":"Herrero-Herranz","year":"2008","journal-title":"Neurobiol Dis"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh626","article-title":"Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis","volume":"128","author":"Pomeroy","year":"2005","journal-title":"Brain"},{"key":"B320","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-510X(84)90145-X","article-title":"Necessity of continuous antigenic stimulation by the locally retained antigens in chronic relapsing experimental allergic encephalomyelitis","volume":"66","author":"Tabira","year":"1984","journal-title":"J Neurol Sci"},{"key":"B321","article-title":"The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in Guinea pigs","volume":"146","author":"Tabira","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh550","article-title":"Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice","volume":"128","author":"Bannerman","year":"2005","journal-title":"Brain"},{"key":"B323","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-60761-720-4_19","article-title":"Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler\u2019s virus-induced demyelinating disease","volume":"900","author":"McCarthy","year":"2012","journal-title":"Methods Mol Biol"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-009-9179-x","article-title":"Neuropathogenesis of Theiler\u2019s murine encephalomyelitis virus infection, an animal model for multiple sclerosis","volume":"5","author":"Tsunoda","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-5274(00)00236-8","article-title":"Mouse hepatitis virus","volume":"4","author":"Haring","year":"2001","journal-title":"Curr Opin Microbiol"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2008.07.014","article-title":"Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus","volume":"39","author":"Matas-Rico","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-017-8442-1","article-title":"Models for studying myelination, demyelination and remyelination","volume":"19","author":"Osorio-Querejeta","year":"2017","journal-title":"Neuromolecular Med"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2007.05335.x","article-title":"Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models","volume":"25","author":"Magalon","year":"2007","journal-title":"Eur J Neurosci"},{"key":"B329","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-540-73677-6_8","article-title":"Remyelination in experimental models of toxin-induced demyelination","volume":"318","author":"Blakemore","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L","article-title":"Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement\/anti-galactocerebroside: a comparative study","volume":"25","author":"Woodruff","year":"1999","journal-title":"Glia"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7224","article-title":"Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination","volume":"160","author":"Levine","year":"1999","journal-title":"Exp Neurol"},{"key":"B332","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0092-8674(94)90419-7","article-title":"High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice","volume":"78","author":"Lafaille","year":"1994","journal-title":"Cell"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3412","article-title":"Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor","volume":"97","author":"Waldner","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J Exp Med"},{"key":"B335","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2014.06.004","article-title":"From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development","volume":"54","author":"Ben-Nun","year":"2014","journal-title":"J Autoimmun"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324044","article-title":"Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis","volume":"34","author":"Ellmerich","year":"2004","journal-title":"Eur J Immunol"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-41138","article-title":"Current disease-modifying therapies in multiple sclerosis","volume":"23","author":"Kieseier","year":"2003","journal-title":"Semin Neurol"},{"key":"B338","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.7.1431","article-title":"T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy","volume":"123","author":"Schmidt","year":"2000","journal-title":"Brain"},{"key":"B340","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0165-5728(97)00207-5","article-title":"Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease promoting mechanisms","volume":"84","author":"van der Meide","year":"1998","journal-title":"J Neuroimmunol"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.1038\/nri3192","article-title":"The storm has cleared: lessons from the CD28 superagonist TGN1412 trial","volume":"12","author":"Hunig","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600876804","article-title":"Oral tolerance: therapeutic implications for autoimmune diseases","volume":"13","author":"Faria","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"B344","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1342","article-title":"The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis","volume":"51","author":"Noseworthy","year":"1998","journal-title":"Neurology"},{"key":"B345","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.nbd.2023.106230","article-title":"An overall view of the most common experimental models for multiple sclerosis","volume":"184","author":"Dedoni","year":"2023","journal-title":"Neurobiol Dis"},{"key":"B346","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B347","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"B348","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"B349","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000733","article-title":"Recommendations of the Alzheimer\u2019s disease-related dementias conference","volume":"83","author":"Montine","year":"2014","journal-title":"Neurology"},{"key":"B350","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.00328","article-title":"Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches","volume":"6","author":"Snyder","year":"2015","journal-title":"Front Psychol"},{"key":"B351","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B352","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.61","article-title":"Vascular parkinsonism\u2013characteristics, pathogenesis and treatment","volume":"11","author":"Korczyn","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: Potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann Neurol"},{"key":"B354","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"B355","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0271678X16679420","article-title":"Age-associated physiological and pathological changes at the blood-brain barrier: A review","volume":"37","author":"Erdo","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"B356","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071632","article-title":"Age-associated changes in the immune system and blood(-)Brain barrier functions","volume":"20","author":"Erickson","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1990.tb00007.x","article-title":"Intraoperative tissue expansion using a Foley catheter following excision of a basal cell carcinoma","volume":"16","author":"Greenbaum","year":"1990","journal-title":"J Dermatol Surg Oncol"},{"key":"B358","doi-asserted-by":"publisher","first-page":"431470","DOI":"10.1155\/2011\/431470","article-title":"Blood-brain barrier breakdown and blood-brain communication in neurological and psychiatric diseases","author":"Friedman","year":"2011","journal-title":"Cardiovasc Psychiatry Neurol 2011"},{"key":"B359","doi-asserted-by":"publisher","first-page":"765923","DOI":"10.1155\/2011\/765923","article-title":"Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy","volume":"2011","author":"Tomkins","year":"2011","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"B360","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevC.42.631","article-title":"Neutron hole strength distribution of the 2f7\/2 state of 207Pb","volume":"42","author":"Majumdar","year":"1990","journal-title":"Phys Rev C Nucl Phys"},{"key":"B361","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/17460441.2017.1253676","article-title":"New experimental models of the blood-brain barrier for CNS drug discovery","volume":"12","author":"Kaisar","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"B362","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-020-00187-3","article-title":"In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication","volume":"17","author":"Erickson","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"B363","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cobme.2017.11.002","article-title":"Modeling the blood-brain barrier: Beyond the endothelial cells","volume":"5","author":"Gastfriend","year":"2018","journal-title":"Curr Opin BioMed Eng"},{"key":"B364","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2011.05.012","article-title":"Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models","volume":"199","author":"Hatherell","year":"2011","journal-title":"J Neurosci Methods"},{"key":"B365","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(81)90382-1","article-title":"Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail\u2013chick transplantation chimeras","volume":"84","author":"Stewart","year":"1981","journal-title":"Dev Biol"},{"key":"B366","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164594","article-title":"Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature","volume":"322","author":"Stenman","year":"2008","journal-title":"Science"},{"key":"B367","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1242\/jcs.103.1.23","article-title":"Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier","volume":"103","author":"Abbott","year":"1992","journal-title":"J Cell Sci"},{"key":"B368","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00006","article-title":"HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P","volume":"12","author":"Annunziata","year":"1998","journal-title":"AIDS"},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1016\/S1385-299X(00)00020-9","article-title":"Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro","volume":"5","author":"Franke","year":"2000","journal-title":"Brain Res Brain Res Protoc"},{"key":"B370","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"B371","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00123-8","article-title":"Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes","volume":"12","author":"Gaillard","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"B372","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2009.05.072","article-title":"Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness","volume":"1284","author":"Cohen-Kashi Malina","year":"2009","journal-title":"Brain Res"},{"key":"B373","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-452-0_28","article-title":"An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes","volume":"814","author":"Abbott","year":"2012","journal-title":"Methods Mol Biol"},{"key":"B374","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.tiv.2007.12.016","article-title":"An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening","volume":"22","author":"Culot","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"B375","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.091","article-title":"A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters","volume":"1150","author":"Perriere","year":"2007","journal-title":"Brain Res"},{"key":"B376","doi-asserted-by":"publisher","DOI":"10.55782\/ane-2011-1828","article-title":"In vitro models of the blood-brain barrier","volume":"71","author":"Wilhelm","year":"2011","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"B377","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.06.057","article-title":"Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance","volume":"1521","author":"Patabendige","year":"2013","journal-title":"Brain Res"},{"key":"B378","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9237-6","article-title":"Paracellular tightness and claudin-5 expression is increased in the BCEC\/astrocyte blood-brain barrier model by increasing media buffer capacity during growth","volume":"12","author":"Helms","year":"2010","journal-title":"AAPS J"},{"key":"B379","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B380","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/glia.10205","article-title":"Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury","volume":"42","author":"Descamps","year":"2003","journal-title":"Glia"},{"key":"B381","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2006.08.006","article-title":"Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages","volume":"50","author":"Veszelka","year":"2007","journal-title":"Neurochem Int"},{"key":"B382","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.08.008","article-title":"Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier","volume":"190","author":"Wong","year":"2004","journal-title":"Exp Neurol"},{"key":"B383","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","article-title":"The influence of cytokines on the integrity of the blood-brain barrier in vitro","volume":"64","author":"de Vries","year":"1996","journal-title":"J Neuroimmunol"},{"key":"B384","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490410602","article-title":"Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin","volume":"41","author":"Deli","year":"1995","journal-title":"J Neurosci Res"},{"key":"B385","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2990.2010.01140.x","article-title":"Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain","volume":"37","author":"Greenwood","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B386","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.12.1127","article-title":"Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells","volume":"60","author":"Biernacki","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"B387","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2010.09.076","article-title":"Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study","volume":"1367","author":"von Wedel-Parlow","year":"2011","journal-title":"Brain Res"},{"key":"B388","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.09.028","article-title":"Differential expression of selectins by mouse brain capillary endothelial cells in vitro in response to distinct inflammatory stimuli","volume":"392","author":"Coisne","year":"2006","journal-title":"Neurosci Lett"},{"key":"B389","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700281","article-title":"Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium","volume":"85","author":"Coisne","year":"2005","journal-title":"Lab Invest"},{"key":"B390","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12987-017-0068-z","article-title":"Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs)","volume":"14","author":"DeStefano","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"B391","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2045-8118-8-4","article-title":"Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle","volume":"8","author":"Engelhardt","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"B392","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J Clin Invest"},{"key":"B393","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12974-020-01810-8","article-title":"Immuno-metabolic impact of the multiple sclerosis patients\u2019 sera on endothelial cells of the blood-brain barrier","volume":"17","author":"Sheikh","year":"2020","journal-title":"J Neuroinflammation"},{"key":"B394","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.3.391","article-title":"Migration of multiple sclerosis lymphocytes through brain endothelium","volume":"59","author":"Prat","year":"2002","journal-title":"Arch Neurol"},{"key":"B395","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1008666","article-title":"Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line","volume":"86","author":"Bahbouhi","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B396","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2202-12-40","article-title":"The role of shear stress in Blood-Brain Barrier endothelial physiology","volume":"12","author":"Cucullo","year":"2011","journal-title":"BMC Neurosci"},{"key":"B397","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1038\/ncomms15623","article-title":"Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents","volume":"8","author":"Cho","year":"2017","journal-title":"Nat Commun"},{"key":"B398","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/srep01500","article-title":"Multicellular self-assembled spheroidal model of the blood brain barrier","volume":"3","author":"Urich","year":"2013","journal-title":"Sci Rep"},{"key":"B399","doi-asserted-by":"publisher","first-page":"15222","DOI":"10.1038\/srep15222","article-title":"Three-dimensional blood-brain barrier model for in vitro studies of neurovascular pathology","volume":"5","author":"Cho","year":"2015","journal-title":"Sci Rep"},{"key":"B400","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1038\/s41598-018-25603-5","article-title":"Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling","volume":"8","author":"Nzou","year":"2018","journal-title":"Sci Rep"},{"key":"B401","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29112469","article-title":"The application of ultrasmall gold nanoparticles (2 nm) functionalized with doxorubicin in three-dimensional normal and glioblastoma organoid models of the blood-brain barrier","volume":"29","author":"Kostka","year":"2024","journal-title":"Molecules"},{"key":"B402","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-020-66487-8","article-title":"Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction","volume":"10","author":"Nzou","year":"2020","journal-title":"Sci Rep"},{"key":"B403","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/s41598-020-75125-2","article-title":"Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model","volume":"10","author":"Sokolova","year":"2020","journal-title":"Sci Rep"},{"key":"B404","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2020.04.023","article-title":"Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model","volume":"111","author":"Sokolova","year":"2020","journal-title":"Acta Biomater"},{"key":"B405","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/srep04160","article-title":"A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources","volume":"4","author":"Lippmann","year":"2014","journal-title":"Sci Rep"},{"key":"B406","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2019.05.008","article-title":"A simplified, fully defined differentiation scheme for producing blood-brain barrier endothelial cells from human iPSCs","volume":"12","author":"Neal","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B407","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.04.021","article-title":"Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits","volume":"19","author":"Lim","year":"2017","journal-title":"Cell Rep"},{"key":"B408","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.2017.142.issue-1","article-title":"Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality","volume":"142","author":"Patel","year":"2017","journal-title":"J Neurochem"},{"key":"B409","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.stem.2017.04.002","article-title":"Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier","volume":"20","author":"Vatine","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B410","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00818","article-title":"Minimum transendothelial electrical resistance thresholds for the study of small and large molecule drug transport in a human in vitro blood-brain barrier model","volume":"13","author":"Mantle","year":"2016","journal-title":"Mol Pharm"},{"key":"B411","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00441","article-title":"Analysis of cancer-targeting alkylphosphocholine analogue permeability characteristics using a human induced pluripotent stem cell blood-brain barrier model","volume":"13","author":"Clark","year":"2016","journal-title":"Mol Pharm"},{"key":"B412","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat Commun"},{"key":"B413","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B414","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2017.00087","article-title":"Modeling neurovascular disorders and therapeutic outcomes with human-induced pluripotent stem cells","volume":"5","author":"Bosworth","year":"2017","journal-title":"Front Bioeng Biotechnol"},{"key":"B415","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0081-4","article-title":"Induction of myelinating oligodendrocytes in human cortical spheroids","volume":"15","author":"Madhavan","year":"2018","journal-title":"Nat Methods"},{"key":"B416","doi-asserted-by":"publisher","first-page":"054124","DOI":"10.1063\/1.4934713","article-title":"Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor","volume":"9","author":"Brown","year":"2015","journal-title":"Biomicrofluidics"},{"key":"B417","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-012-9680-5","article-title":"Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures","volume":"14","author":"Yeon","year":"2012","journal-title":"BioMed Microdevices"},{"key":"B418","doi-asserted-by":"publisher","DOI":"10.1039\/c2lc41208j","article-title":"SyM-BBB: a microfluidic Blood Brain Barrier model","volume":"13","author":"Prabhakarpandian","year":"2013","journal-title":"Lab Chip"},{"key":"B419","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12987-018-0092-7","article-title":"Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation","volume":"15","author":"Katt","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"B420","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.biomaterials.2018.10.023","article-title":"Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior","author":"Linville","year":"2019","journal-title":"Biomaterials"},{"key":"B421","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.07.014","article-title":"3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes","volume":"180","author":"Campisi","year":"2018","journal-title":"Biomaterials"},{"key":"B422","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1038\/s41598-017-07416-0","article-title":"A low permeability microfluidic blood-brain barrier platform with direct contact between perfusable vascular network and astrocytes","volume":"7","author":"Bang","year":"2017","journal-title":"Sci Rep"},{"key":"B423","doi-asserted-by":"publisher","first-page":"025017","DOI":"10.1088\/1758-5090\/ab6d36","article-title":"Drug compound screening in single and integrated multi-organoid body-on-a-chip systems","volume":"12","author":"Skardal","year":"2020","journal-title":"Biofabrication"},{"key":"B424","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2020.02.015","article-title":"Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform","volume":"106","author":"Rajan","year":"2020","journal-title":"Acta Biomater"},{"key":"B425","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18788769","article-title":"In-vitro blood-brain barrier modeling: A review of modern and fast-advancing technologies","volume":"38","author":"Sivandzade","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"B426","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12101293","article-title":"A microfluidic in vitro three-dimensional dynamic model of the blood-brain barrier to study the transmigration of immune cells","volume":"12","author":"Meena","year":"2022","journal-title":"Brain Sci"},{"key":"B427","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1250123","article-title":"Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions","volume":"16","author":"Nair","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B428","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30238-8","article-title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial","volume":"18","author":"Cohen","year":"2019","journal-title":"Lancet Neurol"},{"key":"B429","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial","volume":"57","author":"Johnson","year":"2001","journal-title":"1995. Neurol"},{"key":"B430","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl J Med"},{"key":"B431","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00700-0","article-title":"Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, double-blind, phase III EVOLVE-MS-2 study","volume":"34","author":"Naismith","year":"2020","journal-title":"CNS Drugs"},{"key":"B432","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30239-X","article-title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial","volume":"18","author":"Comi","year":"2019","journal-title":"Lancet Neurol"},{"key":"B433","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902533","article-title":"A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis","volume":"362","author":"Giovannoni","year":"2010","journal-title":"N Engl J Med"},{"key":"B434","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1128\/CMR.17.1.174-207.2004","article-title":"Theiler\u2019s virus infection: a model for multiple sclerosis","volume":"17","author":"Oleszak","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"B435","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-010-9202-2","article-title":"Pathogenesis of murine coronavirus in the central nervous system","volume":"5","author":"Bender","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"B436","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-77-2-281","article-title":"Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis","volume":"77","author":"Amor","year":"1996","journal-title":"J Gen Virol"},{"key":"B437","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"key":"B438","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh516","article-title":"Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide","volume":"128","author":"Felts","year":"2005","journal-title":"Brain"},{"key":"B439","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B440","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-8993(98)01282-7","article-title":"An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol","volume":"818","author":"Franke","year":"1999","journal-title":"Brain Res"},{"key":"B441","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb01236.x","article-title":"An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro","volume":"54","author":"Dehouck","year":"1990","journal-title":"J Neurochem"},{"key":"B442","doi-asserted-by":"publisher","DOI":"10.3791\/4022","article-title":"Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model","author":"Burek","year":"2012","journal-title":"J Vis Exp"},{"key":"B443","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00230","article-title":"A novel transwell blood brain barrier model using primary human cells","volume":"13","author":"Stone","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B444","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.1065193","article-title":"A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity","volume":"16","author":"Barberio","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B445","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.172320","article-title":"In vitro model of the blood-brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells","volume":"10","author":"Wang","year":"2015","journal-title":"Neural Regener Res"},{"key":"B446","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.76","article-title":"Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier","volume":"5","author":"Bernas","year":"2010","journal-title":"Nat Protoc"},{"key":"B447","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"key":"B448","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/mpat.2000.0406","article-title":"Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells","volume":"30","author":"Stins","year":"2001","journal-title":"Microb Pathog"},{"key":"B449","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084179","article-title":"Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes","volume":"9","author":"Boyer-Di Ponio","year":"2014","journal-title":"PLoS One"},{"key":"B450","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099733","article-title":"A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells","volume":"9","author":"Cecchelli","year":"2014","journal-title":"PLoS One"},{"key":"B451","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B452","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010048","article-title":"An improved in vitro blood-brain barrier model for the evaluation of drug permeability using transwell with shear stress","volume":"16","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"key":"B453","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.06.083","article-title":"Simplified in vitro 3D co-culture-based blood-brain barrier model using transwell","volume":"620","author":"Kim","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B454","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1038\/s41598-020-60689-w","article-title":"A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation","volume":"10","author":"Elbakary","year":"2020","journal-title":"Sci Rep"},{"key":"B455","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41467-019-13896-7","article-title":"Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms","volume":"11","author":"Ahn","year":"2020","journal-title":"Nat Commun"},{"key":"B456","doi-asserted-by":"publisher","DOI":"10.3390\/mi11010021","article-title":"In vitro blood-brain barrier-integrated neurological disorder models using a microfluidic device","volume":"11","author":"Choi","year":"2019","journal-title":"Micromachines (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1595276\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:32Z","timestamp":1749528632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1595276\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":456,"alternative-id":["10.3389\/fimmu.2025.1595276"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1595276","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1595276"}}